mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PADI4
Gene summary
Basic gene Info.Gene symbolPADI4
Gene namepeptidyl arginine deiminase, type IV
SynonymsPAD|PAD4|PADI5|PDI4|PDI5
CytomapUCSC genome browser: 1p36.13
Type of geneprotein-coding
RefGenesNM_012387.2,
DescriptionHL-60 PADPADI-H proteinpeptidyl arginine deiminase, type Vprotein-arginine deiminase type IVprotein-arginine deiminase type-4
Modification date20141207
dbXrefs MIM : 605347
HGNC : HGNC
Ensembl : ENSG00000159339
HPRD : 05635
Vega : OTTHUMG00000002371
ProteinUniProt: Q9UM07
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PADI4
BioGPS: 23569
PathwayNCI Pathway Interaction Database: PADI4
KEGG: PADI4
REACTOME: PADI4
Pathway Commons: PADI4
ContextiHOP: PADI4
ligand binding site mutation search in PubMed: PADI4
UCL Cancer Institute: PADI4
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0018101protein citrullination21584310
GO:0036413histone H3-R26 citrullination15339660
GO:0036414histone citrullination15339660


Top
Ligand binding site mutations for PADI4
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
E474E474KBLCA1
D388P387TLUAD1
Q397G399ESKCM1
P584P584LSKCM1
D165A163SSKCM1
F634F633LSTAD1
R639R639KUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PADI4
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
Q397G399E0.11387808
D388P387T-1.5588275
R639R639K-1.4883414
D165A163S-1.0171284
F634F633L-0.94503981
E474E474K-0.73238623
P584P584L-0.41963936
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PADI4 from PDB

Top
Differential gene expression and gene-gene network for PADI4
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PADI4 and the right PPI network was created from samples without mutations in the LBS of PADI4. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PADI4
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0003873Arthritis, Rheumatoid72AlteredExpression, Biomarker, GeneticVariation
umls:C0007097Carcinoma2Biomarker
umls:C0024667Mammary Neoplasms, Animal1Biomarker
umls:C0024668Mammary Neoplasms, Experimental1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PADI4
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|nutraceuticalDB00155L-CitrullineSmall molecule
ApprovedDB00207AzithromycinSmall molecule
Approved|investigational|vet_approvedDB00254DoxycyclineSmall molecule
Approved|vet_approvedDB00759TetracyclineSmall molecule
Approved|vet_approvedDB01082StreptomycinSmall molecule
ExperimentalDB07449N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDESmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PADI4 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
CACALCIUM(2+)1wd9AD165
CACALCIUM(2+)1wd9AD165
CACALCIUM(2+)1wdaAD165
CACALCIUM(2+)1wdaAD165
CACALCIUM(2+)2dewXD165
CACALCIUM(2+)2dewXD165
CACALCIUM(2+)2dexXD165
CACALCIUM(2+)2dexXD165
CACALCIUM(2+)2deyXD165
CACALCIUM(2+)2deyXD165
CACALCIUM(2+)2dw5AD165
CACALCIUM(2+)2dw5AD165
CACALCIUM(2+)3b1tAD165
CACALCIUM(2+)3b1tAD165
CACALCIUM(2+)3b1uAD165
CACALCIUM(2+)3b1uAD165
CACALCIUM(2+)4dktAD165
CACALCIUM(2+)4dktAD165
CACALCIUM(2+)4x8gAD165
CACALCIUM(2+)4x8gAD165
CACALCIUM(2+)1wd9AD388
CACALCIUM(2+)1wdaAD388
CACALCIUM(2+)2dewXD388
CACALCIUM(2+)2dexXD388
CACALCIUM(2+)2deyXD388
CACALCIUM(2+)2dw5AD388
CACALCIUM(2+)3b1tAD388
CACALCIUM(2+)3b1uAD388
CACALCIUM(2+)4dktAD388
CACALCIUM(2+)4x8gAD388
3YZ[(3S,4R)-3-AMINO-4-HYDROXYPIPERIDIN-1-YL]{2-[1- (CYCLOPROPYLMETHYL)-1H-PYRROLO[2,3-B]PYRIDIN-2-YL]-7- METHOXY-1-METHYL-1H-BENZIMIDAZOL-5-YL}METHANONE4x8cAE474 P584 F634
3Z0[(3R)-3-AMINOPIPERIDIN-1-YL][2-(1-ETHYL-1H-PYRROLO[2,3- B]PYRIDIN-2-YL)-7-METHOXY-1-METHYL-1H-BENZIMIDAZOL-5- YL]METHANONE4x8gAE474 P584 F634
CACALCIUM(2+)4dktAQ397
BAGN-[(E)-1-AMINO-5-(DIAMINOMETHYLIDENEAMINO)-1-HYDROXYPENT-1-EN-2-YL]BENZAMIDE1wdaAR639
IIIPeptide ligand (THR,ALA,ARG,LYS,SER)2dewXR639
IIIPeptide ligand (ALA,PRO,ARG,LYS,GLN)2dexXR639
IIIPeptide ligand (ACE,SER,GLY,ARG,GLY,LYS)2deyXR639
BFB(S)-N-ALPHA-BENZOYL-N5-(2-FLUORO-1-IMINOETHYL)-L-ORNITHINE AMIDE2dw5AR639
YCLO-CL-AMIDINE3b1tAR639
YFFO-F-AMIDINE3b1uAR639
IIIPeptide ligand (ASP,ARG,NH2)4dktAR639


Top
Conservation information for LBS of PADI4
Multiple alignments for Q9UM07 in multiple species
LBSAA sequence# speciesSpecies
A581FSKAEAFFPNM1Homo sapiens
A581NSKAQAFFPNM1Mus musculus
A581NPKAEAFFPNM1Rattus norvegicus
C645HGEVHCGTNVR2Homo sapiens, Rattus norvegicus
C645NGEVHCGTNVR1Mus musculus
D155LLVNCDRDNLE1Homo sapiens
D155LLVNCDKEDPQ1Mus musculus
D155LLVNCDKEDPK1Rattus norvegicus
D157VNCDRDNLESS1Homo sapiens
D157VNCDKEDPQAS1Mus musculus
D157VNCDKEDPKSS1Rattus norvegicus
D165ESSAMDCEDDE1Homo sapiens
D165QASGMDFEDDK1Mus musculus
D165KSSGMDFEDDK1Rattus norvegicus
D168AMDCEDDEVLD1Homo sapiens
D168GMDFEDDKILD1Mus musculus
D168GMDFEDDKVLD1Rattus norvegicus
D176VLDSEDLQDMS1Homo sapiens
D176ILDNKDLQDMS1Mus musculus
D176VLDNKDLQDMS1Rattus norvegicus
D179NKDLQDMSPMT2Mus musculus, Rattus norvegicus
D179SEDLQDMSLMT1Homo sapiens
D344EEENMDDQWMQ1Homo sapiens
D344EEENIDDQWMQ1Mus musculus
D344EEENQDDQWMQ1Rattus norvegicus
D350DQWMQDEMEIG3Homo sapiens, Mus musculus, Rattus norvegicus
D369LPVVFDSPRDR2Mus musculus, Rattus norvegicus
D369LPVVFDSPRNR1Homo sapiens
D388RVMGPNFGYVT2Mus musculus, Rattus norvegicus
D388RVMGPDFGYVT1Homo sapiens
D473FVGHVDEFLSF2Mus musculus, Rattus norvegicus
D473SVGHVDEFLSF1Homo sapiens
E170DCEDDEVLDSE1Homo sapiens
E170DFEDDKILDNK1Mus musculus
E170DFEDDKVLDNK1Rattus norvegicus
E175EVLDSEDLQDM1Homo sapiens
E175KILDNKDLQDM1Mus musculus
E175KVLDNKDLQDM1Rattus norvegicus
E252TDFYVEGLAFP2Mus musculus, Rattus norvegicus
E252MDFYVEALAFP1Homo sapiens
E351QWMQDEMEIGY3Homo sapiens, Mus musculus, Rattus norvegicus
E353MQDEMEIGYIQ3Homo sapiens, Mus musculus, Rattus norvegicus
E411AFGNLEVSPPV2Mus musculus, Rattus norvegicus
E411SFGNLEVSPPV1Homo sapiens
E474VGHVDEFLSFV3Homo sapiens, Mus musculus, Rattus norvegicus
E580EFSKAEAFFPN1Homo sapiens
E580GNSKAQAFFPN1Mus musculus
E580GNPKAEAFFPN1Rattus norvegicus
F407TGLDAFGNLEV2Mus musculus, Rattus norvegicus
F407SGLDSFGNLEV1Homo sapiens
F582SKAEAFFPNMV1Homo sapiens
F582SKAQAFFPNMV1Mus musculus
F582PKAEAFFPNMV1Rattus norvegicus
F583KAEAFFPNMVN2Homo sapiens, Rattus norvegicus
F583KAQAFFPNMVN1Mus musculus
F634FINDFFTYHIR1Homo sapiens
F634FINDFYTYHVY1Mus musculus
F634FINDFYSYHMY1Rattus norvegicus
G408GLDAFGNLEVS2Mus musculus, Rattus norvegicus
G408GLDSFGNLEVS1Homo sapiens
H471WLFVGHVDEFL2Mus musculus, Rattus norvegicus
H471WLSVGHVDEFL1Homo sapiens
H640TYHIRHGEVHC1Homo sapiens
H640TYHVYNGEVHC1Mus musculus
H640SYHMYHGEVHC1Rattus norvegicus
K362IQAPHKTLPVV3Homo sapiens, Mus musculus, Rattus norvegicus
K377RDRGLKDFPVK2Mus musculus, Rattus norvegicus
K377RNRGLKEFPIK1Homo sapiens
L410DAFGNLEVSPP2Mus musculus, Rattus norvegicus
L410DSFGNLEVSPP1Homo sapiens
M180KDLQDMSPMTL2Mus musculus, Rattus norvegicus
M180EDLQDMSLMTL1Homo sapiens
N153AILLVNCDKED2Mus musculus, Rattus norvegicus
N153AILLVNCDRDN1Homo sapiens
N373FDSPRDRGLKD2Mus musculus, Rattus norvegicus
N373FDSPRNRGLKE1Homo sapiens
N585EAFFPNMVNML2Homo sapiens, Rattus norvegicus
N585QAFFPNMVNML1Mus musculus
N588FPNMVNMLVLG3Homo sapiens, Mus musculus, Rattus norvegicus
P371VVFDSPRDRGL2Mus musculus, Rattus norvegicus
P371VVFDSPRNRGL1Homo sapiens
P584AEAFFPNMVNM2Homo sapiens, Rattus norvegicus
P584AQAFFPNMVNM1Mus musculus
Q346ENMDDQWMQDE1Homo sapiens
Q346ENIDDQWMQDE1Mus musculus
Q346ENQDDQWMQDE1Rattus norvegicus
Q349DDQWMQDEMEI3Homo sapiens, Mus musculus, Rattus norvegicus
Q397VTRGPQTGGIS1Homo sapiens
Q397VTRKLYMSELT1Mus musculus
Q397VTRGLYRAEVT1Rattus norvegicus
R372VFDSPRDRGLK2Mus musculus, Rattus norvegicus
R372VFDSPRNRGLK1Homo sapiens
R374DSPRDRGLKDF2Mus musculus, Rattus norvegicus
R374DSPRNRGLKEF1Homo sapiens
R639FTYHIRHGEVH1Homo sapiens
R639YTYHVYNGEVH1Mus musculus
R639YSYHMYHGEVH1Rattus norvegicus
S370PVVFDSPRDRG2Mus musculus, Rattus norvegicus
S370PVVFDSPRNRG1Homo sapiens
S468FSDWLFVGHVD2Mus musculus, Rattus norvegicus
S468YSDWLSVGHVD1Homo sapiens
V469SDWLFVGHVDE2Mus musculus, Rattus norvegicus
V469SDWLSVGHVDE1Homo sapiens
W347NMDDQWMQDEM1Homo sapiens
W347NIDDQWMQDEM1Mus musculus
W347NQDDQWMQDEM1Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas